**Part 4**

**Molecular Dynamics Simulations** 

302 Molecular Interactions

[103] David, L.; Feige, J. J.; Bailly, S., Emerging role of bone morphogenetic proteins in

[104] Kan, L.; Hu, M.; Gomes, W. A.; Kessler, J. A., Transgenic mice overexpressing BMP4

[105] Lounev, V. Y.; Ramachandran, R.; Wosczyna, M. N.; Yamamoto, M.; Maidment, A. D.;

[106] Yu, P. B.; Deng, D. Y.; Lai, C. S.; Hong, C. C.; Cuny, G. D.; Bouxsein, M. L.; Hong, D.

[107] Medici, D.; Shore, E. M.; Lounev, V. Y.; Kaplan, F. S.; Kalluri, R.; Olsen, B. R.,

[108] Chan, C. K.; Chen, C. C.; Luppen, C. A.; Kim, J. B.; DeBoer, A. T.; Wei, K.; Helms, J. A.;

haematopoietic stem-cell niche formation. *Nature* 2009, 457, (7228), 490-4. [109] Horowitz, M. C.; Lorenzo, J. A., The origins of osteoclasts. *Curr Opin Rheumatol* 2004,

[110] Kaneko, H.; Arakawa, T.; Mano, H.; Kaneda, T.; Ogasawara, A.; Nakagawa, M.;

[111] Simonet, W. S.; Lacey, D. L.; Dunstan, C. R.; Kelley, M.; Chang, M. S.; Luthy, R.;

[112] Lacey, D. L.; Timms, E.; Tan, H. L.; Kelley, M. J.; Dunstan, C. R.; Burgess, T.; Elliott, R.;

[113] Abe, E.; Yamamoto, M.; Taguchi, Y.; Lecka-Czernik, B.; O'Brien, C. A.; Economides, A.

adult mice: antagonism by noggin. *J Bone Miner Res* 2000, 15, (4), 663-73. [114] Itoh, K.; Udagawa, N.; Katagiri, T.; Iemura, S.; Ueno, N.; Yasuda, H.; Higashio, K.;

osteoclast differentiation and activation. *Cell* 1998, 93, (2), 165-76.

receptors in mature osteoclasts. *Bone* 2000, 27, (4), 479-86.

heterotopic [corrected] ossification. *Nat Med* 2008, 14, (12), 1363-9.

develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. *Am J Pathol* 

Shore, E. M.; Glaser, D. L.; Goldhamer, D. J.; Kaplan, F. S., Identification of progenitor cells that contribute to heterotopic skeletogenesis. *J Bone Joint Surg Am* 

W.; McManus, P. M.; Katagiri, T.; Sachidanandan, C.; Kamiya, N.; Fukuda, T.; Mishina, Y.; Peterson, R. T.; Bloch, K. D., BMP type I receptor inhibition reduces

Conversion of vascular endothelial cells into multipotent stem-like cells. *Nat Med* 

Kuo, C. J.; Kraft, D. L.; Weissman, I. L., Endochondral ossification is required for

Toyama, Y.; Yabe, Y.; Kumegawa, M.; Hakeda, Y., Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP

Nguyen, H. Q.; Wooden, S.; Bennett, L.; Boone, T.; Shimamoto, G.; DeRose, M.; Elliott, R.; Colombero, A.; Tan, H. L.; Trail, G.; Sullivan, J.; Davy, E.; Bucay, N.; Renshaw-Gegg, L.; Hughes, T. M.; Hill, D.; Pattison, W.; Campbell, P.; Sander, S.; Van, G.; Tarpley, J.; Derby, P.; Lee, R.; Boyle, W. J., Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. *Cell* 1997, 89, (2), 309-

Colombero, A.; Elliott, G.; Scully, S.; Hsu, H.; Sullivan, J.; Hawkins, N.; Davy, E.; Capparelli, C.; Eli, A.; Qian, Y. X.; Kaufman, S.; Sarosi, I.; Shalhoub, V.; Senaldi, G.; Guo, J.; Delaney, J.; Boyle, W. J., Osteoprotegerin ligand is a cytokine that regulates

N.; Stahl, N.; Jilka, R. L.; Manolagas, S. C., Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from

Quinn, J. M.; Gillespie, M. T.; Martin, T. J.; Suda, T.; Takahashi, N., Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. *Endocrinology* 

angiogenesis. *Cytokine Growth Factor Rev* 2009, 20, (3), 203-12.

2004, 165, (4), 1107-15.

2009, 91, (3), 652-63.

2010, 16, (12), 1400-6.

16, (4), 464-8.

19.

2001, 142, (8), 3656-62.
